Skip to main content

Journals in Health

    • Med

      • ISSN: 2666-6340
      Med is a flagship clinical and translational research monthly journal published by Cell Press, the global publisher of trusted and authoritative science journals including Cell, Chem, and Joule. Our mission is to accelerate translation of bench research to the clinic by providing a communication forum for the exchange of knowledge, fresh ideas, and thought-leadership among translational researchers, clinicians, and Biotech and Pharma scientists as well as other medical research stakeholders. Our goal is to sustainably and ethically improve health globally.Med publishes rigorously vetted original research and state-of-the-art Review and Perspective articles across the translational and clinical continuum. Our translational research articles are deeply rooted in understanding disease mechanisms, with demonstrable functional impact and broad transformative insights. Our clinical studies cover case reports, first-in-human studies, and large-scale clinical trials, including phase IV, which have the potential to change the course of medical research and improve clinical practice.We are interested in research with likely immediate impact on clinical therapy. These include clinical studies, translational research papers addressing disease mechanism and/or therapies, biotechnology and engineering advances with important clinical impact, and resources (such as informational databases) of broad medical utility. Topics of interest for the journal include but are not limited to:Aging and health-span interventions: sarcopenia; senescence and senolytic treatments; dietary interventions; hormonal disordersBiomedical engineering – new device optimization and diagnostic toolsCancer: immuno-oncology; tumor evolution and cancer genetics; surgery and therapeutic modalitiesCardiovasc... and metabolic disease: heart disease; diabetes; obesity; NAFLD/NASHGenetics and cell-based therapies: medical genomics; CRISPR-based; RNAi; stem cells; organoids; transplantationHealt... economics and public policy: global challenges; health access; public health interventions; clinical practicesHuman microbiome: mechanistic studies of the human microbiomes impact on diseaseImmunology: allergy and inflammation; autoimmunity; innate immunity; graft-versus host disease; vaccinologyInfectiou... diseases: HIV/AIDS; SARS; ebola; other bacterial, viral, fungal, or parasitic infections; infectious diseases epidemiology; antimicrobials and resistanceNeurology: Alzheimers disease; dementia; cognitive dysfunctions; brain-vascular dysfunction; Parkinsons and movement disorders; amyotrophic lateral sclerosis; depression; neuroengineering therapiesVisit the Cell Press website for more information about Med - http://www.cell.com/...
    • The Lancet Rheumatology

      • ISSN: 2665-9913
      The Lancet Rheumatology is an independent journal committed to publishing content relevant to rheumatology specialists worldwide, with a focus on studies that advance clinical practice, challenge the status quo, and advocate change in health policy. The journal publishes clinical research (with a focus on clinical trials), expert reviews, and provocative comment and opinion relating to the diagnosis and classification, management, and prevention of rheumatic diseases, including arthritic, musculoskeletal, and connective tissue diseases, as well as disorders of the immune system. The journal also publishes high-quality human translational studies that are supported by robust clinical data, with priority given to studies that identify potential new therapeutic targets, advance efforts toward precision medicine, or have the potential to directly inform future clinical trials.With a strong clinical focus, The Lancet Rheumatology provides an independent voice for the rheumatology community and advocates strongly for the improved lives of patients with rheumatic diseases around the globe.
    • The Lancet Respiratory Medicine

      • ISSN: 2213-2600
      The Lancet Respiratory Medicine is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The journal is the global leader for essential original research in critical care and respiratory medicine, and delivers expert review, candid commentary, and breaking news, providing a clear, independent perspective about the clinical advances and practice-changing research shaping these fields globally.
    • The Lancet Gastroenterology & Hepatology

      • ISSN: 2468-1253
      The Lancet Gastroenterology & Hepatology is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The journal publishes original research, expert review, opinion, and news covering international issues, providing a clear, independent perspective about the clinical advances and practice-changing research shaping these specialties globally.The Lancet Gastroenterology & Hepatology publishes papers that reflect the rich variety of ongoing clinical research in these fields, especially in the areas of inflammatory bowel diseases, NAFLD and NASH, functional gastrointestinal disorders, digestive cancers, and viral hepatitis.
    • Cancer Treatment Reviews

      • ISSN: 0305-7372
      Cancer Treatment Reviews is an international journal that provides state of the art, authoritative review articles to the clinician and researcher to keep them abreast of modern concepts and the latest developments in cancer treatment research.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support CenterJournal of Cancer Treatment Reviews' Inclusion and Diversity PledgeThis journal pledges to maintain diversity on the editorial team. This sits within Elsevier's broader ongoing inclusion & diversity efforts. Equity and inclusion in publishing is critically important for scientific excellence and innovation. We believe passionately in the power of an inclusive publishing environment, not only to do what is right, but to enrich, strengthen and advance us all.
    • The Lancet Diabetes & Endocrinology

      • ISSN: 2213-8587
      The Lancet Diabetes & Endocrinology is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The journal is the global leader for essential original research in diabetes and endocrinology and delivers expert review and candid commentary, providing a clear, independent perspective about the clinical advances and practice-changing research shaping these fields globally.The Lancet Diabetes & Endocrinology publishes papers that reflect the rich variety of ongoing clinical research in these fields, in particular in the areas of diabetes, obesity, nutrition and metabolism, osteoporosis, adrenal disorders, bone metabolism, growth disorders, lipid disorders, neuroendocrinology, paediatric endocrinology, pituitary disorders, reproductive endocrinology, and thyroid disorders.
    • Molecular Therapy

      • ISSN: 1525-0016
      Molecular Therapy Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy is dedicated to promoting the sciences in genetics, medicine, and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy's 2024 impact factor is 12.To accommodate the rapid growth of Molecular Therapy, articles will be submitted and published in one of the following subsections (for section editors, please see the editorial board page):Biomarker and therapeutic target identificationCell therapyClinical gene and cell therapiesEpigenome editingGenome editingImmunotherapy... diagnostics and imagingNon-viral gene therapyRNA therapiesSmall-molec... therapiesVaccine developmentViral gene therapyVisit the Cell Press website for more information about Molecular Therapy - http://www.cell.com/...
    • Trends in Cancer

      • ISSN: 2405-8033
      Trends in Cancer is a new member of the Trends review journals, offering concise and engaging expert commentary articles that address key frontline research topics and cutting-edge advances in the rapidly changing field of cancer discovery and medicine. The journal provides a unique platform for multidisciplinary information, discussion and education that is valuable for scientists, clinicians, and policy makers, as well as patients and advocates. The latest opportunities, challenges and potential impact of basic, translational and clinical findings, industry R&D, technology and innovation, ethics, or cancer policy and funding are equally presented and debated in an authoritative but reader-friendly format.Critical issues to be covered in the journal include: Adult and Pediatric Cancers; Personalized Medicine; Tumor Microenvironment, Resistance and Metastasis; Immunotherapy; Metabolism; Genetics and Epigenetics; Diagnostics, Biomarkers and Treatment; Epidemiology and Cancer Prevention; Cancer related Ethics, Policy and Funding Initiatives.Visit the Cell Press website for more information about Trends in Cancer - http://www.cell.com/...
    • Atherosclerosis

      • ISSN: 0021-9150
      Cardiovascular disease (CVD) causes one third of all deaths worldwide and is a major threat to global health. Atherosclerosis aims to provide a comprehensive platform for researchers, clinicians and healthcare professionals to share the latest findings and advances in the field of atherosclerosis. Atherosclerosis covers a wide range of topics, including:Pathophysi... and Mechanisms: We explore the intricate cellular and molecular processes involved in atherogenesis, from the initial formation of fatty streaks to the development of complex plaques. We also welcome studies on cardiac biology and disease.Risk Factors: We consider manuscripts that examine both traditional and emerging risk factors for atherosclerosis, such as dyslipidaemia, hypertension, diabetes mellitus, thrombosis and genetic predisposition.Preve... of CVD: Since prevention will become a major focus in the future (see e.g. the European Cardiovascular Health Plan), an important focus will be on preventive strategies, including lifestyle modifications and pharmacological interventions.Diagno... Techniques: We features articles on cutting-edge diagnostic techniques, ranging from invasive procedures such as selective coronary arteriography to non-invasive techniques such as blood biomarkers.Treatment Approaches: Atherosclerosis covers the latest developments in the treatment of atherosclerosis, including lipid-lowering therapies, anti-inflammatory treatments and novel targeted approaches aimed at modifying disease progression and improving clinical outcomes.Translation... Research: We bridges the gap between basic science and clinical practice by highlighting translational studies that bring laboratory findings closer to practical applications in patient care.By fostering collaboration and knowledge exchange between researchers and clinicians, Atherosclerosis aims to accelerate progress in the understanding, prevention and treatment of atherosclerosis, ultimately improving the lives of the millions of people affected by this pervasive disease.